Engineered T-Cell Therapy

Engineered T cells are the result of turning a therapeutic process into a product capable of overcoming checkpoint inhibition, and are the future of adoptive immunotherapy. Cytokine release syndrome,” a storm of molecules generated as the cells fights the cancer. Instead of an antibody, single-chain target domain, he used a human cytokine, IL-13, with a mutation in the sequence that gave high affinity for IL-13 receptor α2. These cells were infused intra cranially, establishing the safety of intracranial administration with some antitumor responses.

  • CAR Strategies in Solid Tumours
  • Prolongation of T-Cell Response by OX40 CC-Signaling CARS
  • Proffered Paper: A New PD-1-CD28 Chimeric Receptor Overcomes PD1-Mediated Immune Suppression in Adoptive T-Cell Therapy
  • Proffered Paper: In-Vivo Testing of PSMA-Targeted T-Cell Immunotherapy for Prostate Cancer

Related Conference of Engineered T-Cell Therapy

June 29-July 01, 2017

8th European Immunology Conference

Madrid, Spain
July 03-05, 2017

9th Asia-Pacific Global Summit on Healthcare & Immunology

Kuala Lumpur, Malaysia
July 12-13, 2017

3rd World Conference on Parasitology & Pathogenesis

Chicago, Illinois, USA
September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
September 11-12, 2017

7th World Congress on Immunology

Amsterdam, Netherlands
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE
April 16-17, 2018

EuroSciCon Conference on StemCell

Amsterdam, Netherlands
July 05-07, 2018

EuroSciCon Conference on Immunology

Vienna, Austria

Engineered T-Cell Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in